Net Worth Advisory Group’s West Pharmaceutical WST Stock Holding History

Net Worth Advisory Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$680K	Sell	1,863 -70	-4%	-$24.7K	0.17%	145
2026 Q2	$694K	Sell	1,933 -198	-9%	-$60.5K	0.17%	137
2026 Q1	$534K	Buy	2,131 +356	+20%	+$88.6K	0.11%	190
2025 Q4	$488K	Sell	1,775 -312	-15%	-$85.3K	0.1%	216
2025 Q3	$547K	Sell	2,087 -1,687	-45%	-$410K	0.16%	150
2025 Q2	$826K	Buy	3,774 +922	+32%	+$197K	0.18%	106
2025 Q1	$639K	Buy	2,852 +1,004	+54%	+$277K	0.2%	109
2024 Q4	$605K	Sell	1,848 -227	-11%	-$71.4K	0.18%	134
2024 Q3	$623K	Buy	+2,075	New	+$635K	0.18%	149

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Net Worth Advisory Group's WST Position: Q3 2026 in Review

Net Worth Advisory Group reduced its West Pharmaceutical (WST) stake by 3.6% in Q3 2026, selling an estimated $24.7K and leaving 1,863 shares worth $680K. The position accounts for 0.17% of the portfolio, ranked #145.

Net Worth Advisory Group first reported a position in WST in Q3 2024 and has held it in 9 quarters since. The position peaked at $826K in Q2 2025. 175 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Net Worth Advisory Group held 1,863 shares of West Pharmaceutical worth $680K as of Q3 2026.
Net Worth Advisory Group sold 70 West Pharmaceutical shares in Q3 2026, an estimated $24.7K.
West Pharmaceutical made up 0.17% of Net Worth Advisory Group's portfolio in Q3 2026, its #145 holding.
Net Worth Advisory Group first reported a position in West Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
Net Worth Advisory Group's West Pharmaceutical position peaked at $826K in Q2 2025.
175 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Net Worth Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.